The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to ...

Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are ...

a responsive and personalized pain management platform that powers the HFX iQ spinal cord stimulation (SCS) system. In addition to the U.S. market release, Nevro introduced the HFX iQ SCS system ...

C. In a move to provide advanced solutions for chronic pain sufferers, OrthoNebraska is now offering minimally invasive ...

Nevro's comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...

(AP) — Nevro Corp. (NVRO) on Tuesday reported a loss ... The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also topped ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The ...